Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17151-17200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02928978
Ruxolitinib for Premalignant Breast Disease
PHASE2
Active, not recruiting
100 participants
Started: May 13, 2018 · Completed: Jun 30, 2026
4 conditions
3 sponsors
8 locations
NCT03965481
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer
NA
Active, not recruiting
21 participants
Started: May 12, 2018 · Completed: Apr 30, 2027
2 conditions
2 sponsors
1 location
NCT03730454
Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair
NA
Active, not recruiting
142 participants
Started: May 11, 2018 · Completed: Feb 28, 2026
2 conditions
1 sponsor
10 locations
NCT03488394
Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant
PHASE1/PHASE2
Active, not recruiting
8 participants
Started: May 11, 2018 · Completed: Mar 31, 2028
1 condition
2 sponsors
1 location
NCT03548961
Organ Preservation in Early Rectal Cancer Patients
PHASE2
Active, not recruiting
19 participants
Started: May 11, 2018 · Completed: Mar 1, 2027
1 condition
1 sponsor
1 location
NCT03999151
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)
NA
Active, not recruiting
204 participants
Started: May 11, 2018 · Completed: Aug 31, 2028
1 condition
2 sponsors
1 location
NCT03652337
Meibomian Gland Dysfunction Management
NA
Active, not recruiting
60 participants
Started: May 10, 2018 · Completed: Apr 10, 2019
2 conditions
2 sponsors
1 location
NCT03453567
Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice
N/A
Active, not recruiting
900 participants
Started: May 10, 2018 · Completed: Dec 15, 2030
2 conditions
2 sponsors
3 locations
NCT03444844
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
PHASE1/PHASE2
Active, not recruiting
60 participants
Started: May 10, 2018 · Completed: Jul 31, 2022
2 conditions
2 sponsors
1 location
NCT03381872
Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease
NA
Active, not recruiting
1,639 participants
Started: May 10, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03902600
A Study of Photon and Proton Chemoradiotherapy As Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer
N/A
Active, not recruiting
103 participants
Started: May 10, 2018 · Completed: May 15, 2035
1 condition
1 sponsor
2 locations
NCT03473249
Effectiveness of Contrast-Enhanced Ultrasound
PHASE4
Active, not recruiting
120 participants
Started: May 9, 2018 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT03549442
Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma
PHASE1
Active, not recruiting
40 participants
Started: May 9, 2018 · Completed: Mar 31, 2036
1 condition
2 sponsors
1 location
NCT03593356
Baby's First Years
NA
Active, not recruiting
1,000 participants
Started: May 9, 2018 · Completed: Aug 31, 2028
3 conditions
11 sponsors
1 location
NCT03531736
T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia
PHASE1
Active, not recruiting
17 participants
Started: May 9, 2018 · Completed: May 31, 2026
1 condition
1 sponsor
2 locations
NCT03533283
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
PHASE1/PHASE2
Active, not recruiting
211 participants
Started: May 8, 2018 · Completed: Oct 16, 2026
1 condition
1 sponsor
19 locations
NCT03381274
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
PHASE1/PHASE2
Active, not recruiting
43 participants
Started: May 8, 2018 · Completed: Apr 16, 2026
1 condition
1 sponsor
13 locations
NCT03476330
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
PHASE2
Active, not recruiting
48 participants
Started: May 8, 2018 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT03527719
China Rural Hypertension Control Project
NA
Active, not recruiting
33,995 participants
Started: May 8, 2018 · Completed: Dec 31, 2026
1 condition
9 sponsors
1 location
NCT04329962
Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy Adults
NA
Active, not recruiting
12 participants
Started: May 8, 2018 · Completed: Jul 10, 2026
2 conditions
1 sponsor
1 location
NCT03511352
Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging
NA
Active, not recruiting
78 participants
Started: May 8, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03495297
A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing
NA
Active, not recruiting
965 participants
Started: May 7, 2018 · Completed: Jul 31, 2025
1 condition
2 sponsors
32 locations
NCT03418844
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NA
Active, not recruiting
268 participants
Started: May 7, 2018 · Completed: Dec 31, 2025
3 conditions
2 sponsors
19 locations
NCT03558438
Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function
N/A
Active, not recruiting
802 participants
Started: May 7, 2018 · Completed: May 31, 2025
2 conditions
1 sponsor
13 locations
NCT03604198
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
PHASE2
Active, not recruiting
125 participants
Started: May 7, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
48 locations
NCT03673293
Measuring Postoperative Mobility, Gait Symmetry and Feedback Following TJA
N/A
Active, not recruiting
150 participants
Started: May 5, 2018 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT03386734
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
NA
Active, not recruiting
989 participants
Started: May 3, 2018 · Completed: May 31, 2029
1 condition
3 sponsors
106 locations
NCT03441113
Extended Access of Momelotinib in Adults With Myelofibrosis
PHASE2
Active, not recruiting
237 participants
Started: May 3, 2018 · Completed: Dec 31, 2026
4 conditions
1 sponsor
224 locations
NCT03469960
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
PHASE3
Active, not recruiting
265 participants
Started: May 2, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
47 locations
NCT03500328
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NA
Active, not recruiting
900 participants
Started: May 2, 2018 · Completed: Aug 1, 2026
1 condition
3 sponsors
47 locations
NCT03428477
EPA for Metastasis Trial 2
PHASE3
Active, not recruiting
418 participants
Started: May 2, 2018 · Completed: Apr 30, 2026
2 conditions
3 sponsors
13 locations
NCT03401788
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
PHASE2
Active, not recruiting
50 participants
Started: May 2, 2018 · Completed: Mar 29, 2026
6 conditions
1 sponsor
11 locations
NCT03483012
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
PHASE2
Active, not recruiting
6 participants
Started: May 1, 2018 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05247632
Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study
N/A
Active, not recruiting
2,290 participants
Started: May 1, 2018 · Completed: Jul 1, 2028
1 condition
3 sponsors
2 locations
NCT05685810
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
N/A
Active, not recruiting
3,029 participants
Started: May 1, 2018 · Completed: Jan 31, 2030
7 conditions
23 sponsors
1 location
NCT03522831
CF Bronchodilation
NA
Active, not recruiting
20 participants
Started: May 1, 2018 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT03708952
Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases
N/A
Active, not recruiting
25,000 participants
Started: May 1, 2018 · Completed: May 1, 2028
2 conditions
3 sponsors
2 locations
NCT03278119
Sleep Aging and Risk for Alzheimer's 2.0
N/A
Active, not recruiting
158 participants
Started: May 1, 2018 · Completed: Dec 25, 2025
2 conditions
2 sponsors
1 location
NCT03539575
CB1R in Synthetic Psychoactive Cannabinoids
NA
Active, not recruiting
15 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT03745521
Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners
N/A
Active, not recruiting
226 participants
Started: May 1, 2018 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03422393
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
PHASE1
Active, not recruiting
24 participants
Started: May 1, 2018 · Completed: Aug 31, 2028
2 conditions
2 sponsors
1 location
NCT02645266
Mean Visual Acuity Changes Following Five Injections of Aflibercept
NA
Active, not recruiting
48 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03834844
Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
NA
Active, not recruiting
50 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03400085
Pilot Study of an mHealth Intervention for Living Donor Follow-up
NA
Active, not recruiting
400 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
3 conditions
4 sponsors
2 locations
NCT03523312
Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
PHASE2
Active, not recruiting
47 participants
Started: Apr 30, 2018 · Completed: Apr 30, 2026
1 condition
1 sponsor
8 locations
NCT03057054
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
PHASE3
Active, not recruiting
173 participants
Started: Apr 30, 2018 · Completed: Jun 30, 2026
4 conditions
2 sponsors
43 locations
NCT03419481
Pembrolizumab in Hepatocellular Carcinoma
PHASE2
Active, not recruiting
30 participants
Started: Apr 30, 2018 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT03355976
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
PHASE2
Active, not recruiting
46 participants
Started: Apr 30, 2018 · Completed: Mar 31, 2026
5 conditions
5 sponsors
4 locations
NCT03449108
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
PHASE2
Active, not recruiting
30 participants
Started: Apr 27, 2018 · Completed: Apr 30, 2027
16 conditions
3 sponsors
1 location
NCT03569241
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
PHASE2
Active, not recruiting
196 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2026
4 conditions
2 sponsors
29 locations
Previous
1
More pages
341
342
343
344
345
346
347
More pages
431
Next